A Unified Two-Tiered Grading Scheme for Low Risk Salivary Gland Cancer: A Proposal to Simplify Pathologic Grading Based on Mitotic Activity and Tumor Necrosis
In brief
A mitosis-and-necrosis score classifies 19% of low-risk salivary cancers as high grade
In a retrospective cohort of 621 salivary gland carcinomas generally considered low risk, a proposed grading scheme based on mitotic activity and tumor necrosis classified 19% as high grade. These tumors had worse disease-specific and recurrence-related outcomes, even after accounting for stage and other factors; whether the scheme improves treatment decisions remains unknown.
- Journal
- Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (Q1)
- Published
- 18 November 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Nora Katabi, Dibisha Roy, Ian Ganly, Luc G T Morris, Lillian A Boe, Nadeem Riaz, et al.
- PMID
- 43051593
- DOI
- 10.1016/j.modpat.2026.101120
Why clinicians should know about it
- Picked for Pathology and Forensic Medicine (top studies of the week, 22 November 2026): Proposes prognostically relevant histologic grading criteria
Abstract
Salivary gland carcinomas are rare and histologically diverse. The current pathology reporting protocols mandate inclusion of histologic grade in resections for salivary gland carcinoma. However, many carcinoma types lack a well-established grading scheme. We herein explored the prognostic significance of a two-tiered grading scheme using mitotic count (MC) ≥ 5/2 mm2 and/or tumor necrosis to define high-grade tumors in a retrospective cohort of 621 salivary gland carcinomas generally considered as low risk. The frequency of high-grade tumors was 19% overall, and in a descending order in each cancer type was 43% in acinic cell carcinoma, 30% in polymorphous adenocarcinoma, 20% in hyalinizing clear cell carcinoma and basal cell adenocarcinoma, 10% in secretory carcinoma and epithelial-myoepithelial carcinoma, 7% in mucoepidermoid carcinoma, and 0% in non-apocrine intraductal carcinoma. High-grade carcinomas were associated with advanced pT and pN categories, larger tumor size, higher frequency of perineural invasion and lymphovascular invasion, and positive resection margin. On multivariable survival analysis, high grade was associated with decreased disease-specific, disease-free, locoregional recurrence-free, and distant metastatic-free survival independent of pT, pN, and other prognostic pathologic factors. In conclusion, the proposed unified grading system based on MC and tumor necrosis may reliably stratify salivary gland carcinomas that are generally considered low risk into two prognostically distinct groups: high grade and low grade. Careful examination of MC and tumor necrosis and accurate grading based on these parameters are essential for prognostication and for guiding clinical management for patients with salivary gland carcinomas.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.